Results 1-2 of 2 for long segment:8902092
- Written Answers — Department of Health: Medicinal Products (23 Apr 2024)
David Cullinane: 670. To ask the Minister for Health the reason reimbursement support for OzempicĀ® (Semaglutide) is only available to those with eligibility under the general medical services scheme or the long-term illness scheme, and is not available on the drugs payment scheme; and if he will make a statement on the matter. [17966/24]
- Written Answers — Department of Health: Medicinal Products (23 Apr 2024)
Stephen Donnelly: ...reimbursement support to the approved indication. It is for this reason that reimbursement for Semaglutide (OzempicĀ®) is confined to those with eligibility under the General Medical Services Scheme (GMS) or the Long-Term Illness (LTI) scheme and is not made available on the Drugs Payment Scheme. In accordance with the provisions of the Health Act 1970 (as amended), eligibility for...